Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Long-Term Debt Repayments (2016 - 2023)

Dexcom (DXCM) has disclosed Long-Term Debt Repayments for 6 consecutive years, with $136.8 million as the latest value for Q4 2023.

  • Quarterly Long-Term Debt Repayments changed N/A to $136.8 million in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $136.8 million through Dec 2024, changed 0.0% year-over-year, with the annual reading at $787.3 million for FY2023, N/A changed from the prior year.
  • Long-Term Debt Repayments for Q4 2023 was $136.8 million at Dexcom, up from $75.0 million in the prior quarter.
  • The five-year high for Long-Term Debt Repayments was $136.8 million in Q4 2023, with the low at $136.8 million in Q4 2023.